IXICO plc

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:07 2025-02-12 EST			5-day change	1st Jan Change
12.00 ^GBX	+2.13%		+2.13%	+2.13%

12-10	Ixico Bags Imaging Services Deal with US Client	MT
12-10	IXICO plc Wins US Client Clinical Trial Contract	CI

Ixico Bags Imaging Services Deal with US Client

December 10, 2024 at 08:54 am

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about IXICO plc

Ixico Bags Imaging Services Deal with US Client	12-10	MT
IXICO plc Wins US Client Clinical Trial Contract	12-10	CI
IXICO plc, 2024 Earnings Call, Dec 05, 2024	12-05
IXICO plc, 2024 Earnings Call, Dec 04, 2024	12-04
IXICO plc Reports Earnings Results for the Full Year Ended September 30, 2024	12-04	CI
Medical Imaging Group Ixico Completes Retail Offer	24-10-15	MT
Ixico raises GBP4 million in equity raise at premium price	24-10-09	AN
Ixico Conditionally Raises GBP4 Million via Fundraising	24-10-09	MT
Ixico to Raise Equity via Share Placement, Subscription; Plans Retail Offer	24-10-09	MT
Ixico shares soar as company eyes stronger revenue in second half	24-08-14	AN
Stocks stay upbeat ahead of US CPI data	24-08-14	AN
AIM WINNERS & LOSERS: Ixico expects to beat guidance on contract wins	24-08-14	AN
Ixico Wins New Contract for Imaging Biomarker Services from US Client	24-08-14	MT
Ixico plc Provides Revenue Guidance for the Year Ending 30 September 2024	24-08-14	CI
Ixico names Bram Goorden as next chief executive officer	24-08-05	AN
Ixico Hires New CEO	24-08-05	MT
IXICO plc Appoints Bram Goorden as Chief Executive Officer, Effective 19 August 2024	24-08-05	CI
Ixico Says New Biopharma Partner Joins Huntington's Disease Research Consortium	24-07-29	MT
IXICO plc Announces Further Progress in HD Consortium	24-07-29	CI
Ixico Bags Over GBP1 Million Contract for Parkinsonian Disorder Study	24-06-19	MT
AIM WINNERS & LOSERS: Ixico and Light Science Technologies win deal	24-06-19	AN
Ixico shares jump as wins new pharma contract worth over GBP1 million	24-06-19	AN
IXICO plc Announces New Pharma Client Contract Valued in Excess of £1 Million for A Study of A Parkinsonian Disorder	24-06-19	CI
IXICO plc Signs Contract with Global Alzheimer's Platform Foundation to Support Bio-Hermes 2 Trial	24-05-23	CI
IXICO plc, H1 2024 Earnings Call, May 21, 2024	24-05-21

IXICO plc is a United Kingdom-based medical imaging advanced analytics company. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. Its data platforms include TrialTracker and Assessa. The TrialTracker platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data. Its neuroimaging biomarkers focus area includes Radiological Reads, Volumetric MRI, PET and SPECT, and Advanced MRI.

Employees

Sector

Biotechnology & Medical Research

Calendar

2025-05-26 - Q2 2025 Earnings Release (Projected)

More about the company